PMID: 30013295Jul 18, 2018Paper

Pharmaceutical Approval Update

P & T : a Peer-reviewed Journal for Formulary Management
Mary Choy

Abstract

Fostamatinib (Tavalisse) for thrombocytopenia in adults with chronic immune thrombocytopenia; coagulation factor Xa (recombinant), inactivated-zhzo (Andexxa) for the reversal of anticoagulation; epoetin alfa-epbx (Retacrit), a biosimilar for the treatment of anemia.

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Clinical Journal of the American Society of Nephrology : CJASN
Huub Schellekens
The New England Journal of Medicine
Aneel A Ashrani, S Vincent Rajkumar
The New England Journal of Medicine
Alan S Go, Juan Carlos Ayus
The New England Journal of Medicine
Simon D Roger
© 2022 Meta ULC. All rights reserved